Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:55 pm Sale | 2025-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 5,128,875 4.200% | -2,376,819 (-31.67%) | Filing History |
| 2025-11-14 4:54 pm Sale | 2025-09-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 23,594,831 3.400% | -10,642,948 (-31.09%) | Filing History |
| 2025-11-14 4:54 pm Sale | 2025-09-30 | 13G | Regal Rexnord Corporation RRX | VIKING GLOBAL INVESTORS LP | 3,123,262 4.700% | -306,866 (-8.95%) | Filing History |
| 2025-11-14 4:53 pm Sale | 2025-09-30 | 13G | BioMarin Pharmaceutical Inc. BMRN | VIKING GLOBAL INVESTORS LP | 8,322,179 4.300% | -3,966,432 (-32.28%) | Filing History |
| 2025-11-14 4:53 pm Purchase | 2025-09-30 | 13G | Fortive Corporation FTV | VIKING GLOBAL INVESTORS LP | 20,483,680 6.400% | 3,434,502 (+20.14%) | Filing History |
| 2025-11-14 4:52 pm Sale | 2025-11-14 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 15,893,934 8.200% | -2,708,986 (-14.56%) | Filing History |
| 2025-10-03 4:37 pm Purchase | 2025-09-26 | 13G | PepGen Inc. PEPG | VIKING GLOBAL INVESTORS LP | 3,482,434 5.100% | 2,000,000 (+134.91%) | Filing History |
| 2025-09-24 5:11 pm Purchase | 2025-09-17 | 13G | Oruka Therapeutics, Inc. ORKA | VIKING GLOBAL INVESTORS LP | 2,666,690 5.500% | 2,666,690 (New Position) | Filing History |
| 2025-09-10 4:05 pm Purchase | 2025-09-03 | 13G | Saia, Inc. SAIA | VIKING GLOBAL INVESTORS LP | 1,337,356 5.020% | 1,337,356 (New Position) | Filing History |
| 2025-08-14 8:32 pm Unchanged | 2025-08-14 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 18,602,920 9.700% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:35 pm Sale | 2025-06-30 | 13G | Trevi Therapeutics, Inc. TRVI | VIKING GLOBAL INVESTORS LP | 7,505,694 5.900% | -1,684,792 (-18.33%) | Filing History |
| 2025-08-14 5:34 pm Sale | 2025-06-30 | 13G | APi Group Corporation APG | VIKING GLOBAL INVESTORS LP | 11,537,518 2.800% | -20,768,759 (-64.29%) | Filing History |
| 2025-08-14 5:34 pm Purchase | 2025-06-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | VIKING GLOBAL INVESTORS LP | 8,729,345 9.990% | 2,156,645 (+32.81%) | Filing History |
| 2025-08-14 5:33 pm Sale | 2025-06-30 | 13G | Regal Rexnord Corporation RRX | VIKING GLOBAL INVESTORS LP | 3,430,128 5.200% | -115,984 (-3.27%) | Filing History |
| 2025-08-14 5:32 pm Purchase | 2025-06-30 | 13G | BioMarin Pharmaceutical Inc. BMRN | VIKING GLOBAL INVESTORS LP | 12,288,611 6.400% | 2,535,318 (+25.99%) | Filing History |
| 2025-08-14 5:32 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 34,237,779 5.020% | -11,775,973 (-25.59%) | Filing History |
| 2025-07-24 7:55 pm Purchase | 2025-07-17 | 13G | Fortive Corporation FTV | VIKING GLOBAL INVESTORS LP | 17,049,178 5.020% | 17,049,178 (New Position) | Filing History |
| 2025-07-01 7:49 pm Sale | 2025-06-27 | 13D | BridgeBio Pharma, Inc. BBIO | VIKING GLOBAL INVESTORS LP | 18,602,920 9.800% | -3,452,455 (-15.65%) | Filing History |
| 2025-06-18 6:47 pm Purchase | 2025-06-11 | 13G | Primo Brands Corporation PRMB | VIKING GLOBAL INVESTORS LP | 19,602,116 5.300% | 19,602,116 (New Position) | Filing History |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 46,013,752 6.400% | -8,085,314 (-14.95%) | Filing History |